Literature DB >> 17194544

Eye dominance predicts fMRI signals in human retinotopic cortex.

Janine D Mendola1, Ian P Conner.   

Abstract

There have been many attempts to define eye dominance in normal subjects, but limited consensus exists, and relevant physiological data is scarce. In this study, we consider two different behavioral methods for assignment of eye dominance, and how well they predict fMRI signals evoked by monocular stimulation. Sighting eye dominance was assessed with two standard tests, the Porta Test, and a 'hole in hand' variation of the Miles Test. Acuity dominance was tested with a standard eye chart and with a computerized test of grating acuity. We found limited agreement between the sighting and acuity methods for assigning dominance in our individual subjects. We then compared the fMRI response generated by dominant eye stimulation to that generated by non-dominant eye, according to both methods, in 7 normal subjects. The stimulus consisted of a high contrast hemifield stimulus alternating with no stimulus in a blocked paradigm. In separate scans, we used standard techniques to label the borders of visual areas V1, V2, V3, VP, V4v, V3A, and MT. These regions of interest (ROIs) were used to analyze each visual area separately. We found that percent change in fMRI BOLD signal was stronger for the dominant eye as defined by the acuity method, and this effect was significant for areas located in the ventral occipital territory (V1v, V2v, VP, V4v). In contrast, assigning dominance based on sighting produced no significant interocular BOLD differences. We conclude that interocular BOLD differences in normal subjects exist, and may be predicted by acuity measures.

Entities:  

Mesh:

Year:  2006        PMID: 17194544      PMCID: PMC2740649          DOI: 10.1016/j.neulet.2006.12.012

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  39 in total

1.  Functional magnetic resonance imaging of eye dominance at 4 tesla.

Authors:  A Miki; G T Liu; S A Englander; T G van Erp; G R Bonhomme; D O Aleman; C S Liu; J C Haselgrove
Journal:  Ophthalmic Res       Date:  2001 Sep-Oct       Impact factor: 2.892

Review 2.  What does the dominant eye dominate? A brief and somewhat contentious review.

Authors:  Alistair P Mapp; Hiroshi Ono; Raphael Barbeito
Journal:  Percept Psychophys       Date:  2003-02

3.  Effects of sighting and sensory dominance on monovision high and low contrast visual acuity.

Authors:  M W Robboy; I G Cox; P Erickson
Journal:  CLAO J       Date:  1990 Oct-Dec

4.  A theory of ocular dominance.

Authors:  G L WALLS
Journal:  AMA Arch Ophthalmol       Date:  1951-04

5.  The Psychophysics Toolbox.

Authors:  D H Brainard
Journal:  Spat Vis       Date:  1997

6.  The functional basis of ocular dominance: functional MRI (fMRI) findings.

Authors:  S A Rombouts; F Barkhof; M Sprenger; J Valk; P Scheltens
Journal:  Neurosci Lett       Date:  1996-12-27       Impact factor: 3.046

7.  Human ocular dominance columns as revealed by high-field functional magnetic resonance imaging.

Authors:  K Cheng; R A Waggoner; K Tanaka
Journal:  Neuron       Date:  2001-10-25       Impact factor: 17.173

Review 8.  The dominant eye.

Authors:  C Porac; S Coren
Journal:  Psychol Bull       Date:  1976-09       Impact factor: 17.737

9.  Visual evoked potentials and eye dominance.

Authors:  M Seyal; S Sato; B G White; R J Porter
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1981-11

10.  Ocular dominance in human V1 demonstrated by functional magnetic resonance imaging.

Authors:  R S Menon; S Ogawa; J P Strupp; K Uğurbil
Journal:  J Neurophysiol       Date:  1997-05       Impact factor: 2.714

View more
  14 in total

1.  Retinotopic maps and foveal suppression in the visual cortex of amblyopic adults.

Authors:  Ian P Conner; J Vernon Odom; Terry L Schwartz; Janine D Mendola
Journal:  J Physiol       Date:  2007-07-12       Impact factor: 5.182

2.  The horizontal dark oculomotor rest position.

Authors:  Eun H Kim; Tara L Alvarez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-25       Impact factor: 3.117

3.  Hemispheric differences in electrical and hemodynamic responses during hemifield visual stimulation with graded contrasts.

Authors:  Juanning Si; Xin Zhang; Yujin Zhang; Tianzi Jiang
Journal:  Biomed Opt Express       Date:  2017-03-02       Impact factor: 3.732

4.  Spatial scale and distribution of neurovascular signals underlying decoding of orientation and eye of origin from fMRI data.

Authors:  Jonas Larsson; Charlotte Harrison; Jade Jackson; Seung-Mock Oh; Vaida Zeringyte
Journal:  J Neurophysiol       Date:  2016-11-30       Impact factor: 2.714

5.  Ocular Dominance in Open-angle Glaucoma: The Shifting Trend Depending on Stage of the Disease.

Authors:  Moon Young Choi; Jin A Choi
Journal:  Korean J Ophthalmol       Date:  2022-02-18

6.  Activity in early visual areas predicts interindividual differences in binocular rivalry dynamics.

Authors:  Hiroyuki Yamashiro; Hiroki Yamamoto; Hiroaki Mano; Masahiro Umeda; Toshihiro Higuchi; Jun Saiki
Journal:  J Neurophysiol       Date:  2013-12-18       Impact factor: 2.714

7.  Cerebral Asymmetry of fMRI-BOLD Responses to Visual Stimulation.

Authors:  Anders Hougaard; Bettina Hagström Jensen; Faisal Mohammad Amin; Egill Rostrup; Michael B Hoffmann; Messoud Ashina
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

8.  Ocular dominance and visual function testing.

Authors:  D Lopes-Ferreira; H Neves; A Queiros; M Faria-Ribeiro; S C Peixoto-de-Matos; J M González-Méijome
Journal:  Biomed Res Int       Date:  2013-11-11       Impact factor: 3.411

9.  Neural Correlates of Subliminal Language Processing.

Authors:  Vadim Axelrod; Moshe Bar; Geraint Rees; Galit Yovel
Journal:  Cereb Cortex       Date:  2014-02-20       Impact factor: 5.357

10.  Comparing measurement techniques of accommodative amplitudes.

Authors:  Hamed Momeni-Moghaddam; James Kundart; Farshad Askarizadeh
Journal:  Indian J Ophthalmol       Date:  2014-06       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.